FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Disclosed is transdermal therapeutic system, which includes active substance impermeable back layer, containing active substance, polymer matrix and separable protective layer, wherein active substance is represented by 5-aminolevulinic acid hydrochloride and polymer matrix basic polymer is adhesive polyacrylate. Transdermal therapeutic system is applicable for diagnosing and treating of skin cancer pre-stages, such as actinic keratosis, as well as skin oncological diseases.
EFFECT: transdermal therapeutic system is fairly well sticks to skin and does not cause irritation thereof.
15 cl, 1 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMER ADHESION MATRIX WITH CARBOXYL GROUPS, FORMING SALTS FOR TRANSDERMAL ADMINISTRATION | 2005 |
|
RU2401126C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM AND METHOD FOR PRODUCING THE SYSTEM | 1993 |
|
RU2108812C1 |
| HIGHLY PURE 3,3-DIPHENYLPROPYLAMINO MONOESTERS | 2004 |
|
RU2394019C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL ADMINISTRATION OF GUANFACINE CONTAINING AT LEAST ONE EXCIPIENT | 2018 |
|
RU2812734C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH LEVEL OF USING ACTIVE SUBSTANCE AND DOSE ACCURACY | 2007 |
|
RU2454994C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER | 2018 |
|
RU2792822C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL | 2015 |
|
RU2695785C2 |
| GLUES WITH LOW LEVEL OF RESIDUAL MONOMERS AND A METHOD FOR PREPARATION THEREOF | 1997 |
|
RU2215014C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2020 |
|
RU2791107C1 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 1989 |
|
RU2011384C1 |
